| 2025-05-21 12:00:00 |
Ipsen S.a. - Annual General Meeting Held On 21 May 2025
Annual general meeting of ipsen s.a. held on 21 may 2025 all the resolutions submitted to the shareholders’ vote have been adopted paris, france, 21 may 2025 - ipsen (euronext: ipn; adr: ipsey) announces today that the annual general meeting of the company was held on wednesday 21 may, 2025 at the salons de l’hÔtel des arts et mÉtiers, 9 bis, avenue d’iÉna, 75116 paris (france), under the chairmanship of mr. |
| 2025-05-20 16:10:00 |
Genfit To Receive A €26.5 Million Milestone Payment Following The Approval Of Pricing And Reimbursement Of Ipsen’s Iqirvo® In Italy
Lille (france), cambridge (massachusetts, united states), zurich (switzerland), may 20, 2025 – genfit (nasdaq and euronext: gnft), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that ipsen’s iqirvo®1 has been granted pricing and reimbursement in italy for primary biliary cholangitis (pbc). |
| 2025-04-30 12:00:00 |
Ipsen S.a. - Formalities For Making Available And Consulting Preparatory Documents To The 2025 Annual General Meeting
Information relating to the holding of the combined shareholders’ meeting of 21 may 2025 of ipsen s.a. formalities for making available and consulting preparatory documents to the meeting paris, france, 30 april 2025 - ipsen (euronext: ipn; adr: ipsey) announced today that the shareholders of the company are invited to participate in the combined shareholders’ meeting of ipsen (euronext: ipn; adr: ipsey) to be held on wednesday 21 may 2025 at 3:00 p.m. |
| 2024-10-03 06:30:00 |
Eton Pharmaceuticals, Inc To Acquire Increlex® (mecasermin Injection) From Ipsen
Aligns with eton’s mission to develop and distribute medicines that have a life changing impact for patients with ultra-rare conditions |
| 2024-09-23 01:30:00 |
Genfit: Ipsen’s Iqirvo® (elafibranor) Receives Eu Approval As A First-in-class Treatment For Primary Biliary Cholangitis Following U.s. Fda Accelerated Approval
Lille (france), cambridge (massachusetts, united states), zurich (switzerland), september 23, 2024 - genfit (nasdaq and euronext: gnft), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that the european commission has conditionally approved iqirvo®1 (elafibranor) 80mg tablets for the treatment of primary biliary cholangitis (pbc) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca or as a monotherapy in patients unable to tolerate udca. this follows the positive opinion issued by the committee for medicinal products for human use (chmp) of the european medicines agency (ema) on july 26, 2024 and the u.s. fda accelerated approval on june, 10, 2024 . |
| 2024-08-29 14:14:00 |
SXBzZW7igJ lzIElxaXJ2 byBTaG93cy BTdHJvbmcg U3RhcnQgSW 4gUHJpbWFy eSBCaWxpYX J5IENob2xh bmdpdGlzLC BOb3cgRmFj ZXMgUml2YW xyeSBGcm9t IEdpbGVhZO KAmXMgTGl2 ZGVsemk=
UHJpb3IgdG 8gdGhlIGFw cHJvdmFscy BhbmQgbGF1 bmNoZXMgb2 YgaXFpcnZv IGFuZCBsaX ZkZWx6aSwg dXMgZ2FzdH JvZW50ZXJv bG9naXN0cy Bub3RhYmx5 IGZhdm9yZW QgdGhlIHNl Y29uZCB0by BtYXJrZXQg bGl2ZGVsem kgYXMgdGhl aXIgcHJlZm VycmVkIGFz c2V0LiBwcm lvciB0byB0 aGUgYXBwcm 92YWxzIGFu ZCBsYXVuY2 hlcyBvZiBp cWlydm8gYW 5kIGxpdmRl bHppLCB1cy BnYXN0cm9l bnRlcm9sb2 dpc3RzIG5v dGFibHkgZm F2b3JlZCB0 aGUgc2Vjb2 5kIHRvIG1h cmtldCBsaX ZkZWx6aSBh cyB0aGVpci BwcmVmZXJy ZWQgYXNzZX Qu
|
| 2024-07-26 07:45:00 |
R2VuZml0Oi BQb3NpdGl2 ZSBPcGluaW 9uIEZyb20g RW1hIENvbW 1pdHRlZSBG b3IgSXBzZW 7igJlzIElx aXJ2b8KuIC hlbGFmaWJy YW5vcikgSW 4gUHJpbWFy eSBCaWxpYX J5IENob2xh bmdpdGlz
TGlsbGUgKG ZyYW5jZSks IGNhbWJyaW RnZSAobWFz c2FjaHVzZX R0cywgdW5p dGVkIHN0YX RlcyksIHp1 cmljaCAoc3 dpdHplcmxh bmQpLCBqdW x5IDI2LCAy MDI0IC0gZ2 VuZml0IChu YXNkYXEgYW 5kIGV1cm9u ZXh0OiBnbm Z0KSwgYSBs YXRlLXN0YW dlIGJpb3Bo YXJtYWNldX RpY2FsIGNv bXBhbnkgZG VkaWNhdGVk IHRvIGltcH JvdmluZyB0 aGUgbGl2ZX Mgb2YgcGF0 aWVudHMgd2 l0aCByYXJl IGFuZCBsaW ZlLXRocmVh dGVuaW5nIG xpdmVyIGRp c2Vhc2VzLC B0b2RheSBh bm5vdW5jZW QgdGhlIHBv c2l0aXZlIG 9waW5pb24g aXNzdWVkIG J5IHRoZSBj b21taXR0ZW UgZm9yIG1l ZGljaW5hbC Bwcm9kdWN0 cyBmb3IgaH VtYW4gdXNl IChjaG1wKS BvZiB0aGUg ZXVyb3BlYW 4gbWVkaWNp bmVzIGFnZW 5jeeKAmXMg KGVtYSkgZm 9yIGlwc2Vu 4oCZcyBpcW lydm/CriAo ZWxhZmlicm Fub3IpIGZv ciB0aGUgdH JlYXRtZW50 IG9mIHByaW 1hcnkgYmls aWFyeSBjaG 9sYW5naXRp cyAocGJjKS BpbiBjb21i aW5hdGlvbi B3aXRoIHVy c29kZW94eW Nob2xpYyBh Y2lkICh1ZG NhKSBpbiBh ZHVsdHMgd2 l0aCBhbiBp bmFkZXF1YX RlIHJlc3Bv bnNlIHRvIH VkY2Egb3Ig YXMgYSBtb2 5vdGhlcmFw eSBpbiBwYX RpZW50cyB1 bmFibGUgdG 8gdG9sZXJh dGUgdWRjYS 4=
|
| 2024-07-25 08:18:00 |
SXBzZW4gUy 5hLiBQdWJs aXNoZXMgSX RzIDIwMjQg SGFsZi15ZW FyIFJlcG9y dCAoaGFsZi 15ZWFyIEVu ZGVkIDMwIE p1bmUgMjAy NCk=
SXBzZW4gcy 5hLiBwdWJs aXNoZXMgaX RzIDIwMjQg aGFsZi15ZW FyIHJlcG9y dCAoaGFsZi 15ZWFyIGVu ZGVkIDMwIG p1bmUgMjAy NCkgYXR0YW NobWVudCAy MDI0IGlwc2 VuIGhhbGYt eWVhciBmaW 5hbmNpYWwg cmVwb3J0
|
| 2024-07-25 00:58:00 |
SXBzZW4gQW 5kIERheSBP bmUgRW50ZX IgSW50byBF eGNsdXNpdm UgRXgtdS5z LiBMaWNlbn NpbmcgQWdy ZWVtZW50IF RvIENvbW1l cmNpYWxpem UgVG92b3Jh ZmVuaWIgRm 9yIFRoZSBN b3N0IENvbW 1vbiBDaGls ZGhvb2QgQn JhaW4gVHVt b3I=
UGFyaXMsIG ZyYW5jZSwg YW5kIGJyaX NiYW5lLCBj YWxpZm9ybm lhIHUucy4s IDI1IGp1bH kgMjAyNCAt IGlwc2VuIC hldXJvbmV4 dDogaXBuOy BhZHI6IGlw c2V5KSBhbm QgZGF5IG9u ZSBiaW9waG FybWFjZXV0 aWNhbHMgKG 5hc2RhcTog ZGF3bikgKG RheSBvbmUp LCBhbm5vdW 5jZWQgdG9k YXkgYSBuZX cgZ2xvYmFs IHBhcnRuZX JzaGlwIG91 dHNpZGUgdG hlIHUucy4g Zm9yIHRvdm 9yYWZlbmli LCBhbiBvcm FsLCBvbmNl LXdlZWtseS wgdHlwZSBp aSByYWYgaW 5oaWJpdG9y IGZvciBwZW RpYXRyaWMg bG93IGdyYW RlIGdsaW9t YSAocGxnZy ksIHRoZSBt b3N0IGNvbW 1vbiBmb3Jt IG9mIGNoaW xkaG9vZCBi cmFpbiBjYW 5jZXIsIGkg YW5kIGFueS BmdXR1cmUg aW5kaWNhdG lvbnMgZGV2 ZWxvcGVkIG J5IGRheSBv bmUu
|
| 2024-06-10 17:22:00 |
R2VuZml0Oi BIaXN0b3Jp YyBNaWxlc3 RvbmUgQWNo aWV2ZWQgV2 l0aCBVLnMu IEZkYSBBY2 NlbGVyYXRl ZCBBcHByb3 ZhbCBPZiBJ cHNlbuKAmX MgSXFpcnZv wq4gRm9yIF ByaW1hcnkg QmlsaWFyeS BDaG9sYW5n aXRpcw==
TGlsbGUgKG ZyYW5jZSks IGNhbWJyaW RnZSAobWFz c2FjaHVzZX R0cywgdW5p dGVkIHN0YX RlcyksIHp1 cmljaCAoc3 dpdHplcmxh bmQpLCBqdW 5lIDEwLCAy MDI0IC0gZ2 VuZml0IChu YXNkYXEgYW 5kIGV1cm9u ZXh0OiBnbm Z0KSwgYSBs YXRlLXN0YW dlIGJpb3Bo YXJtYWNldX RpY2FsIGNv bXBhbnkgZG VkaWNhdGVk IHRvIGltcH JvdmluZyB0 aGUgbGl2ZX Mgb2YgcGF0 aWVudHMgd2 l0aCByYXJl IGFuZCBsaW ZlLXRocmVh dGVuaW5nIG xpdmVyIGRp c2Vhc2VzLC B0b2RheSBh bm5vdW5jZW QgdGhlIGFj aGlldmVtZW 50IG9mIGEg aGlzdG9yaW MgY29ycG9y YXRlIG1pbG VzdG9uZTog dGhlIHUucy 4gZm9vZCBh bmQgZHJ1Zy BhZG1pbmlz dHJhdGlvbi AoZmRhKSBh Y2NlbGVyYX RlZCBhcHBy b3ZhbCBvZi BpcWlydm8x IChlbGFmaW JyYW5vciky IDgwIG1nIH RhYmxldHMg 4oCTIGFzIH VudmVpbGVk IHRvZGF5IG J5IGlwc2Vu IChldXJvbm V4dDogaXBu OyBhZHI6IG lwc2V5KSDi gJMgYXMgYS BmaXJzdC1p bi1jbGFzcy B0cmVhdG1l bnQgZm9yIH BiYyBpbiBj b21iaW5hdG lvbiB3aXRo IHVyc29kZW 94eWNob2xp YyBhY2lkIC h1ZGNhKSBp biBhZHVsdH Mgd2l0aCBh biBpbmFkZX F1YXRlIHJl c3BvbnNlIH RvIHVkY2Es IG9yIGFzIG 1vbm90aGVy YXB5IGluIH BhdGllbnRz IHVuYWJsZS B0byB0b2xl cmF0ZSB1ZG NhLg==
|
| 2024-05-28 12:00:00 |
QW5udWFsIE dlbmVyYWwg TWVldGluZy BPZiBJcHNl biBTLmEuIE hlbGQgT24g MjggTWF5ID IwMjQ=
UGFyaXMsIG ZyYW5jZSwg MjggbWF5ID IwMjQgLSB0 aGUgYW5udW FsIGdlbmVy YWwgbWVldG luZyBvZiBp cHNlbiBzLm EuIChldXJv bmV4dDogaX BuOyBhZHI6 IGlwc2V5KS B3YXMgaGVs ZCB0b2RheS BhdCB0aGUg c2Fsb25zIG RlIGzigJlo w5R0ZWwgZG VzIGFydHMg ZXQgbcOJdG llcnMsIDkg YmlzLCBhdm VudWUgZOKA mWnDiW5hLC A3NTExNiBw YXJpcyAoZn JhbmNlKSwg dW5kZXIgdG hlIGNoYWly bWFuc2hpcC BvZiBtci4g bWFyYyBkZS BnYXJpZGVs LCBjaGFpcm 1hbiBvZiB0 aGUgYm9hcm Qgb2YgZGly ZWN0b3JzLC BhbmQgaW4g dGhlIHByZX NlbmNlIG9m IHRoZSBtZW 1iZXJzIG9m IHRoZSBib2 FyZCBvZiBk aXJlY3Rvcn MgYW5kIHRo ZSBncm91cO KAmXMgZXhl Y3V0aXZlIG xlYWRlcnNo aXAgdGVhbS 4=
|
| 2024-05-28 01:00:00 |
RGVzY3JpcH Rpb24gT2Yg VGhlIFJlZ3 VsYXRvcnkg RnJhbWV3b3 JrIE9mIFRo ZSBTaGFyZS BSZXB1cmNo YXNlIFByb2 dyYW0gUHJv cG9zZWQgQn kgVGhlIEJv YXJkIE9mIE RpcmVjdG9y cyBUbyBCZS BBcHByb3Zl ZCBBdCBJcH NlbiBTLmEu 4oCZcyBBbm 51YWwgR2Vu ZXJhbCBNZW V0aW5nIE9u IDI4IE1heS AyMDI0
UGFyaXMsIG ZyYW5jZSwg MjggbWF5ID IwMjQgLcKg aW4gYWNjb3 JkYW5jZSB3 aXRoIHRoZS Bwcm92aXNp b25zIG9mIG FydGljbGUg bC4yMi0xMC 02MiBldCBz ZXEuIG9mIH RoZSBmcmVu Y2ggY29tbW VyY2lhbCBj b2RlLCB0aG UgZXVyb3Bl YW4gcmVndW xhdGlvbiAo ZXUpIG5vID U5Ni8yMDE0 IG9mIHRoZS BldXJvcGVh biBwYXJsaW FtZW50IGFu ZCBvZiB0aG UgY291bmNp bCBvZiAxNi BhcHJpbCAy MDE0LCB0aG UgZGVsZWdh dGVkIHJlZ3 VsYXRpb24g bm8gMjAxNi 8xMDUyIG9m IDggbWFyY2 ggMjAxNiwg YW5kIHRoZS BnZW5lcmFs IHJlZ3VsYX Rpb24gb2Yg dGhlIGZyZW 5jaCBhdXRv cml0w4kgZG VzIG1hcmNo w4lzIGZpbm FuY2llcnMg KGFtZiksIH RoZSBwcmVz ZW50IGRlc2 NyaXB0aW9u IGFpbXMgdG 8gZGVzY3Jp YmUgdGhlIG 9iamVjdGl2 ZXMgYW5kIG NoYXJhY3Rl cmlzdGljcy BvZiB0aGUg cmVwdXJjaG FzZSBieSB0 aGUgY29tcG FueSBvZiBp dHMgb3duIH NoYXJlcywg dGhhdCBpdC Bjb3VsZCBp biB0aGVvcn kgaW1wbGVt ZW50LiB0aG lzIHJlcHVy Y2hhc2UgaX MgcHJvcG9z ZWQgdG8gdG hlIGF1dGhv cml6YXRpb2 4gb2YgdG9k YXnigJlzIC gyOCBtYXkg MjAyNCkgYW 5udWFsIGdl bmVyYWwgbW VldGluZyBp biBpdHMgMT V0aCByZXNv bHV0aW9uLi B0aGUgcHJl bGltaW5hcn kgbm90aWNl IG9mIG1lZX RpbmcsIGlu Y2x1ZGluZy B0aGUgYWdl bmRhIGFuZC B0aGUgZHJh ZnQgcmVzb2 x1dGlvbnMs IGhhcyBiZW VuIHB1Ymxp c2hlZCBpbi B0aGUgYnVs bGV0aW4gZG VzIGFubm9u Y2VzIGzDiW dhbGVzIG9i bGlnYXRvaX JlcyAoYmFs bykgb24gMT cgYXByaWwg MjAyNCBhbm QgdGhlIG5v dGljZSBvZi BtZWV0aW5n IGluIHRoZS BiYWxvIG9u IDYgbWF5ID IwMjQu
|
| 2024-05-07 08:55:00 |
SXBzZW4gUy 5hLiAtIEZv cm1hbGl0aW VzIEZvciBN YWtpbmcgQX ZhaWxhYmxl IEFuZCBDb2 5zdWx0aW5n IFByZXBhcm F0b3J5IERv Y3VtZW50cy BUbyBUaGUg MjAyNCBBbm 51YWwgR2Vu ZXJhbCBNZW V0aW5n
SW5mb3JtYX Rpb24gcmVs YXRpbmcgdG 8gdGhlIGhv bGRpbmcgb2 YgdGhlIGNv bWJpbmVkIH NoYXJlaG9s ZGVyc+KAmS BtZWV0aW5n IG9mIDI4IG 1heSAyMDI0 IG9mIGlwc2 VuIHMuYS4g Zm9ybWFsaX RpZXMgZm9y IG1ha2luZy BhdmFpbGFi bGUgYW5kIG NvbnN1bHRp bmcgcHJlcG FyYXRvcnkg ZG9jdW1lbn RzIHRvIHRo ZSBtZWV0aW 5nIGJvdWxv Z25lLWJpbG xhbmNvdXJ0 LCBmcmFuY2 UsIDcgbWF5 IDIwMjQgLS B0aGUgc2hh cmVob2xkZX JzIG9mIHRo ZSBjb21wYW 55IGFyZSBp bnZpdGVkIH RvIHBhcnRp Y2lwYXRlIG luIHRoZSBj b21iaW5lZC BzaGFyZWhv bGRlcnPigJ kgbWVldGlu ZyBvZiBpcH NlbiAoZXVy b25leHQ6IG lwbjsgYWRy OiBpcHNleS kgdG8gYmUg aGVsZCBvbi B0dWVzZGF5 IDI4wqBtYX kgMjAyNCBh dCAzOjAwIH AubS4=
|
| 2024-02-15 04:00:00 |
SXBzZW4gUy 5hLiBQdWJs aXNoZXMgSX RzIDIwMjMg Q29uc29saW RhdGVkIEZp bmFuY2lhbC BTdGF0ZW1l bnRz
SXBzZW4gcy 5hLiAtIDIw MjMgY29uc2 9saWRhdGVk IGZpbmFuY2 lhbCBzdGF0 ZW1lbnRzIG F0dGFjaG1l bnQgaXBzZW 4gLSAyMDIz IGNvbnNvbG lkYXRlZCBm aW5hbmNpYW wgc3RhdGVt ZW50cw==
|
| 2023-08-16 15:32:00 |
VXMgRmRhIE FwcHJvdmVz IElwc2Vu4o CZcyBTb2hv bm9zdG0gKH BhbG92YXJv dGVuZSkgQ2 Fwc3VsZXMs IFRoZSBGaX JzdCBBbmQg T25seSBUcm VhdG1lbnQg Rm9yIFBlb3 BsZSBXaXRo IEZpYnJvZH lzcGxhc2lh IE9zc2lmaW NhbnMgUHJv Z3Jlc3Npdm E=
UGFyaXMsIG ZyYW5jZSwg MTYgYXVndX N0IDIwMjMg 4oCTIGlwc2 VuIChldXJv bmV4dDogaX BuOyBhZHI6 IGlwc2V5KS Bhbm5vdW5j ZWQgdG9kYX kgYXBwcm92 YWwgYnkgdG hlIHUucy4g Zm9vZCBhbm QgZHJ1ZyBh ZG1pbmlzdH JhdGlvbiAo ZmRhKSBvZi Bzb2hvbm9z 4oSiIChwYW xvdmFyb3Rl bmUpIGNhcH N1bGVzIGFz IGEgcmV0aW 5vaWQgaW5k aWNhdGVkIG ZvciB0aGUg cmVkdWN0aW 9uIGluIHZv bHVtZSBvZi BuZXcgaGV0 ZXJvdG9waW Mgb3NzaWZp Y2F0aW9uIG luIGFkdWx0 cyBhbmQgcG VkaWF0cmlj IHBhdGllbn RzIGFnZWQg OCB5ZWFycy BhbmQgb2xk ZXIgZm9yIG ZlbWFsZXMg YW5kIDEwIH llYXJzIGFu ZCBvbGRlci Bmb3IgbWFs ZXMgd2l0aC BmaWJyb2R5 c3BsYXNpYS Bvc3NpZmlj YW5zIHByb2 dyZXNzaXZh IChmb3ApLg ==
|
